Apella Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72M | Buy |
16,815
+15
| +0.1% | +$3.32K | 0.1% | 125 |
|
|
2025
Q1 | $3.42M | Sell |
16,800
-1
| -0% | -$204 | 0.12% | 106 |
|
|
2024
Q4 | $5.5M | Sell |
16,801
-7
| -0% | -$2.29K | 0.21% | 74 |
|
|
2024
Q3 | $5.04M | Buy |
16,808
+13
| +0.1% | +$3.9K | 0.21% | 67 |
|
|
2024
Q2 | $5.35M | Sell |
16,795
-1
| -0% | -$319 | 0.24% | 62 |
|
|
2024
Q1 | $6.59M | Sell |
16,796
-34
| -0.2% | -$13.3K | 0.33% | 54 |
|
|
2023
Q4 | $5.73M | Sell |
16,830
-115
| -0.7% | -$39.1K | 0.32% | 60 |
|
|
2023
Q3 | $6.36M | Sell |
16,945
-85
| -0.5% | -$31.9K | 0.45% | 47 |
|
|
2023
Q2 | $6.51M | Buy |
+17,030
| New | +$6.51M | 0.46% | 47 |
|
|
2022
Q4 | $4.1M | Sell |
17,400
-210
| -1% | -$49.4K | 0.37% | 54 |
|
|
2022
Q3 | $4.33M | Sell |
17,610
-200
| -1% | -$49.2K | 0.5% | 46 |
|
|
2022
Q2 | $5.39M | Buy |
17,810
+160
| +0.9% | +$48.4K | 0.64% | 37 |
|
|
2022
Q1 | $7.25M | Buy |
17,650
+4,000
| +29% | +$1.64M | 1.02% | 28 |
|
|
2021
Q4 | $6.4M | Sell |
13,650
-90
| -0.7% | -$42.2K | 0.82% | 32 |
|
|
2021
Q3 | $5.83M | Sell |
13,740
-135
| -1% | -$57.3K | 0.84% | 34 |
|
|
2021
Q2 | $4.98M | Hold |
13,875
| – | – | 0.82% | 32 |
|
|
2021
Q1 | $3.91M | Hold |
13,875
| – | – | 1.23% | 26 |
|
|
2020
Q4 | $3.93M | Buy |
13,875
+1,047
| +8% | +$297K | 1.38% | 23 |
|
|
2020
Q3 | $3.53M | Hold |
12,828
| – | – | 1.42% | 22 |
|
|
2020
Q2 | $2.91M | Hold |
12,828
| – | – | 1.36% | 20 |
|
|
2020
Q1 | $1.95M | Buy |
+12,828
| New | +$1.95M | 1.14% | 24 |
|